Business Segments Avicanna Inc. OTC Markets

Stocks

Market Closed - OTC Markets 15:49:59 2026-09-30 EDT			5-day change	1st Jan Change
0.0774 ^USD	+1.84%		+7.50%	-52.25%

08-19	Avicanna Inc. announced that it has received CAD 0.5 million in funding	CI
08-19	Avicanna Closes C$500,000 Private Placement to Pharmaceutical Investor Michael Porter	MT

Breakdown by Business Segment (CAD)

Fiscal Period: December	2021	2022	2023	2024	2025
Medicinal Chemicals and Botanical Products
Pharmaceuticals	3.27M	4.05M	16.79M	25.46M	25.48M
Total Assets	22.3M	17.62M	21.97M	20.12M	21.24M
Interest Expense	-738K	-1.67M	-610K	-334K	-51.84K
Income Tax Expense	13.77K	-	-	-	-
CAPEX	-789K	-66.78K	-44.62K	-403K	-256K
EBT	-16.76M	-14.74M	-8.74M	-3.62M	-2.76M
Gross Profit	2.83M	1.12M	6.66M	12.9M	13.52M
D&A	756K	768K	643K	676K	640K
Net Income	-16.77M	-14.74M	-8.74M	-3.62M	-2.76M
Licensing and Royalty	-	-	-	-	-
Gross Profit	-	-	-	-	-
International and Other	-	-	-	-	-
Gross Profit	-	-	-	-	-
Canadian Medical Cannabis	-	-	-	-	-
Gross Profit	-	-	-	-	-

Geographical breakdown of sales (CAD)

Fiscal Period: December	2021	2022	2023	2024	2025
Canada	-	-	-	23.54M	23.59M
Total Assets	-	-	-	5.71M	5.1M
Gross Profit	-	-	-	11.62M	11.9M
Net Income	-	-	-	-794K	-815K
EBT	-	-	-	-794K	-815K
International	-	-	-	1.92M	1.89M
Total Assets	-	-	-	14.41M	16.15M
Gross Profit	-	-	-	1.27M	1.62M
Net Income	-	-	-	-645K	-735K
EBT	-	-	-	-645K	-735K
South America	-	1.03M	364K	-	-
Total Assets	-	13.91M	14.73M	-	-
Gross Profit	-	23.61K	-704K	-	-
Net Income	-	-	-3.03M	-	-
EBT	-	-4.7M	-3.03M	-	-
Net Income	-	-	-3.27M	-2.18M	-1.21M
EBT	-	-4.32M	-3.27M	-2.18M	-1.21M
	-	-	-	-	1.89M
Rest of World	-	35.41K	-	-	-
Total Assets	-	78.39K	72.77K	-	-
Gross Profit	-	24.84K	-	-	-
Net Income	-	-	-86.76K	-	-
EBT	-	-50.11K	-86.76K	-	-
North America	-	2.98M	16.43M	-	-
Total Assets	-	3.64M	7.16M	-	-
Gross Profit	-	1.07M	7.36M	-	-
Net Income	-	-	-2.35M	-	-
EBT	-	-5.67M	-2.35M	-	-
	-	-	-	-	23.59M